Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Columbia Research Enhanced Value ETF (REVS) belongs to the US Large Cap Value segment. T. Rowe Price Equity Income ETF (TEQI) is part of the US Multi-Factor segment. REVS's top 3 sector exposures are Financials, Health Care and Industrials. In contrast, TEQI's top sector exposures are Financials, Industrials and Health Care. REVS is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.54% for TEQI. REVS is up 2.51% year-to-date (YTD) with +$74M in YTD flows. TEQI performs worse with 1.64% YTD performance, and -$1M in YTD flows. Run a side-by-side ETF comparison of REVS and TEQI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | REVS TEQI | -3.72%-3.82% | +3.44%+3.79% | +2.51%+1.64% | +18.51%+12.75% | +57.22%+45.01% | +75.71%+57.05% |
| Flows | REVS TEQI | +$13M+$2M | +$79M+$11M | +$74M-$1M | +$138M+$45M | +$173M+$202M | +$193M+$277M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | REVS TEQI | +11.36%+10.94% | +16.05%+15.76% | +13.41%+13.34% | +15.12%+15.20% |
| Max drawdown | REVS TEQI | -3.82%-4.10% | -12.32%-12.68% | -16.16%-14.73% | -17.78%-17.81% |
| Max drawdown duration | REVS TEQI | 28d15d | 46d77d | 211d213d | 448d624d |
REVS | TEQI | |
Last sale 3/11/2026 at 1:30 PM | $28.72 | $45.57 |
| Previous close 03/10/2026 | $28.81 | $45.65 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
REVS | TEQI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
REVS | TEQI | |
|---|---|---|
| Last price | $28.72 | $45.57 |
| 1D performance | -0.30% | -0.18% |
| AuM | $214.92 M | $372.53 M |
| E/R | 0.19% | 0.54% |
REVS | TEQI | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Columbia Threadneedle Investments | T. Rowe Price |
| Benchmark | Beta Advantage Research Enhanced U.S. Value Index | - |
| N° of holdings | 281 | 109 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 25, 2019 | June 23, 2020 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
